Literature DB >> 9032480

Biochemical analysis of a bladder-cancer-associated mucin: structural features and epitope characterization.

A Bergeron1, H LaRue, Y Fradet.   

Abstract

Three monoclonal antibodies (mAbs), M344, M300 and M75, were shown to define a unique tumour-associated antigen (TAA) of superficial bladder tumours. The antigenic determinants are expressed on a very-high-molecular-mass component and, in about 50% of the positive samples, one determinant is also detected on a 62 kDa molecular species, observed only under reducing conditions. The objectives of the present study were to characterize further this TAA by analysing (1) the biochemical nature of the epitopes recognized by the three mAbs, and (2) the biochemical and structural features of the molecule bearing them. The antigenicity was resistant to heat denaturation, trypsin and alpha-chymotrypsin treatments but highly sensitive to papain and Pronase digestion. NaIO4 oxidation decreased reactivity to mAbs M344 and M300 but enhanced reactivity to mAb M75. The three determinants were insensitive to beta-galactosidase and alpha-L-fucosidase but were sensitive to Vibrio cholerae neuraminidase. None of the three mAbs reacted with ovine, bovine or porcine submaxillary mucins. Deglycosylation with O-glycosidase or trifluoromethanesulphonic acid completely abolished the reactivity of the mAbs whereas N-glycosidase F deglycosylation had no appreciable effect. The presence on the molecule of cryptic Gal(beta(1-3))GalNAc as a major core disaccharide was demonstrated by a heterologous sandwich assay using mAb M75 and peanut agglutinin. Thiol reduction using beta-mercaptoethanol increased mobility of the high-molecular-mass component in polyacrylamide gels. We thus conclude that mAbs M344 and M300 react with sialylated carbohydrate epitopes, and mAb M75 reacts with a partially cryptic and periodate-resistant sialylated epitope expressed on a typical secreted high-molecular-mass oligomeric mucin which we named MAUB for mucin antigen of the urinary bladder.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9032480      PMCID: PMC1218149          DOI: 10.1042/bj3210889

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  51 in total

1.  Biochemical and immunological properties of the human carcinoma-associated CAR-3 epitope defined by the monoclonal antibody AR-3.

Authors:  M Prat; E Medico; P Rossino; C Garrino; P M Comoglio
Journal:  Cancer Res       Date:  1989-03-15       Impact factor: 12.701

2.  Analysis of a human tumor-associated glycoprotein (TAG-72) identified by monoclonal antibody B72.3.

Authors:  V G Johnson; J Schlom; A J Paterson; J Bennett; J L Magnani; D Colcher
Journal:  Cancer Res       Date:  1986-02       Impact factor: 12.701

3.  Deglycosylation of glycoproteins by trifluoromethanesulfonic acid.

Authors:  A S Edge; C R Faltynek; L Hof; L E Reichert; P Weber
Journal:  Anal Biochem       Date:  1981-11-15       Impact factor: 3.365

4.  "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A.

Authors:  W N Burnette
Journal:  Anal Biochem       Date:  1981-04       Impact factor: 3.365

5.  A 70000-molecular-weight protein isolated from purified pig gastric mucus glycoprotein by reduction of disulphide bridges and its implication in the polymeric structure.

Authors:  J P Pearson; A Allen; S Parry
Journal:  Biochem J       Date:  1981-07-01       Impact factor: 3.857

6.  Functional and structural characteristics of the glycosaminoglycans of the bladder luminal surface.

Authors:  R E Hurst; S W Rhodes; P B Adamson; C L Parsons; J B Roy
Journal:  J Urol       Date:  1987-08       Impact factor: 7.450

7.  Bladder surface glycosaminoglycan: efficient mechanism of environmental adaptation.

Authors:  C L Parsons
Journal:  Urology       Date:  1986-02       Impact factor: 2.649

8.  A simple, non-chromatographic procedure to purify immunoglobulins from serum and ascites fluid.

Authors:  M M McKinney; A Parkinson
Journal:  J Immunol Methods       Date:  1987-02-11       Impact factor: 2.303

9.  Tumor-associated antigens as prognostic factors for recurrence in 382 patients with primary transitional cell carcinoma of the bladder.

Authors:  P Allard; Y Fradet; B Têtu; P Bernard
Journal:  Clin Cancer Res       Date:  1995-10       Impact factor: 12.531

10.  Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.

Authors:  P J Fraker; J C Speck
Journal:  Biochem Biophys Res Commun       Date:  1978-02-28       Impact factor: 3.575

View more
  3 in total

1.  Preclinical evaluation of the novel monoclonal antibody H6-11 for prostate cancer imaging.

Authors:  Hongjun Jin; Mai Xu; Prashanth K Padakanti; Yongjian Liu; Suzanne Lapi; Zhude Tu
Journal:  Mol Pharm       Date:  2013-09-03       Impact factor: 4.939

2.  Overexpression of tumour-associated carbohydrate antigen sialyl-Tn in advanced bladder tumours.

Authors:  José Alexandre Ferreira; Paula A Videira; Luís Lima; Sofia Pereira; Mariana Silva; Mylène Carrascal; Paulo F Severino; Elisabete Fernandes; Andreia Almeida; Céu Costa; Rui Vitorino; Teresina Amaro; Maria J Oliveira; Celso A Reis; Fabio Dall'Olio; Francisco Amado; Lúcio Lara Santos
Journal:  Mol Oncol       Date:  2013-03-21       Impact factor: 6.603

3.  Reduction of Allergic Lung Disease by Mucosal Application of Toxoplasma gondii-Derived Molecules: Possible Role of Carbohydrates.

Authors:  Elke Korb; Mirjana Drinić; Angelika Wagner; Nora Geissler; Aleksandra Inic-Kanada; Roman Peschke; Anja Joachim; Ursula Wiedermann; Irma Schabussova
Journal:  Front Immunol       Date:  2021-03-10       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.